Tate & Lyle PLC

Public consensus   -   Last updated 15/10/25

Reporting currency: GBP
Reporting unit: Millions
 
NO. OF
FORECASTS
FY27
CONSENSUS
15/10/25
FY27
MEDIAN
FY27
MIN
FY27
MAX
Group Income Statement (£m)
Revenue (New segments)
Americas
9
1,017
1,017
957
1,052
Europe, Middle East and Africa
9
642
646
614
673
Asia Pacific
9
384
384
355
405
Revenue - Group
12
2,046
2,048
1,958
2,122
Adjusted EBITDA (New segments)
Americas
9
280
278
267
298
Europe, Middle East and Africa
9
108
109
99
126
Asia Pacific
9
54
54
50
61
Adjusted EBITDA - Group
12
442
442
419
472
Less: Depreciation and adjusted amortisation
12
(137)
(135)
(159)
(121)
Adjusted operating profit
12
306
305
286
336
Net finance expense
12
(40)
(42)
(50)
(24)
Adjusted profit before tax
12
266
265
236
300
Adjusted Profit after Tax (pre excepts and amort)
12
202
200
180
225
Average diluted shares (m) (including impact of share buyback)
12
447.6
449.3
427.0
454.7
Adjusted diluted EPS (p)
12
45.2
45.1
39.8
50.1
Dividend/Share (p)
11
20.3
20.6
15.9
22.0
$/£ assumption (average rate)
7
1.34
1.34
1.33
1.36
€/£ assumption (average rate)
7
1.15
1.15
1.15
1.16
Group Cash Flow Statement (£m)
Adjusted Free cash flow (before exceptional cash flows)
10
212
225
153
281
Other cash flows in the year
Closing net debt
10
(804)
(802)
(928)
(676)

Disclaimer

Tate & Lyle PLC (“Tate & Lyle”) invites registered sell-side analysts that monitor Tate & Lyle’s stock to submit their forecasts to an external, web-based tool managed
by Vuma Financial Limited (“Vuma”), a company independent of Tate & Lyle.

The web-based tool generates an aggregation of publicly available forecasts collated exclusively by Vuma, but only on the basis of information submitted by those
analysts who choose to participate. The arithmetic average of the constituent analyst forecasts is known as “Consensus”. Vuma has no access to Tate & Lyle's
internal forecasts, budgets or any other information which is not publicly available.

Tate & Lyle has not commented on individual forecasts nor does it intend to do so in the future. Tate & Lyle assumes no obligation to update or revise such
information and nothing in this analysis should be taken as a recommendation to buy or sell shares in Tate & Lyle or to take any other action or place any reliance
on the analysis.

Consensus figures are provided for information only, and neither Tate & Lyle nor any of its subsidiary undertakings nor any director, officer or employee of
Tate & Lyle or any of its subsidiary undertakings accepts any responsibility for the accuracy or completeness of forecasts used in this analysis and therefore shall
have no liability whatsoever for the consequences of any reliance or actions taken or not taken based on any of the information in this analysis.